Libertad Fernandez
Medical · Dallas, TXNPI 1174866115
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Novo Nordisk at 28.3% of the total. Reporting peaked in 2022 at $470 and has fallen 60.7% since, to $185 in 2025.
Across 56 payments — averaging $28.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$459
- Idorsia Pharmaceuticals US Inc$157
- GSK$130
- Lilly USA, LLC$117
- Impel Pharmaceuticals Inc.$112
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$100
- plus $545 from 17 others
What the payments were for
- Food & beverage$1,620100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 13 | $459 |
| Idorsia Pharmaceuticals US Inc | 3 | $157 |
| GSK | 2 | $130 |
| Lilly USA, LLC | 3 | $117 |
| Impel Pharmaceuticals Inc. | 2 | $112 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $100 |
| Genentech USA, Inc. | 8 | $95 |
| Noven Therapeutics, LLC | 3 | $49 |
| Gilead | 2 | $46 |
| Pfizer | 2 | $45 |
| AstraZeneca | 3 | $43 |
| Sanofi-aventis U.S. LLC | 1 | $37 |
| Hologic Sales And Service, LLC | 1 | $29 |
| AbbVie | 2 | $25 |
| Amgen | 1 | $25 |
| Amarin Pharma, Inc. | 1 | $25 |
| Dynavax Technologies Corporation | 2 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Ironshore Pharmaceuticals Inc. | 1 | $18 |
| Medtronic | 1 | $16 |
| Orthofix Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,620 in reported general payments places this provider in the 65th percentile of 1,490 medical providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 12 | $56 |
Paid to pharmacies, not to this prescriber.
Other medical in Dallas
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Danny DeckardDallas$101K
- Janine ShinnDallas$84K
- Andrew GarzaDallas$43K
- Alyssa SpiegelDallas$18K
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Shakira CabreraSan Antonio$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.